International consensus statement on allergy and rhinology: rhinosinusitis 2021.
Int Forum Allergy Rhinol
; 11(3): 213-739, 2021 03.
Article
em En
| MEDLINE
| ID: mdl-33236525
ABSTRACT
I. EXECUTIVE SUMMARY:
BACKGROUND:
The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document.METHODS:
ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary.RESULTS:
ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided.CONCLUSION:
This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sinusite
/
Rinite
/
Rinite Alérgica
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Int Forum Allergy Rhinol
Ano de publicação:
2021
Tipo de documento:
Article